Kristian Tonby

3.8k total citations
30 papers, 711 citations indexed

About

Kristian Tonby is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Kristian Tonby has authored 30 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 13 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Kristian Tonby's work include Tuberculosis Research and Epidemiology (15 papers), COVID-19 Clinical Research Studies (7 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Kristian Tonby is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), COVID-19 Clinical Research Studies (7 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Kristian Tonby collaborates with scholars based in Norway, Denmark and South Africa. Kristian Tonby's co-authors include Anne Ma Dyrhol‐Riise, Dag Kvale, Synne Jenum, Michael T. Durheim, Eirik Ikdahl, Eivind Brønstad, Tøri Vigeland Lerum, Ole Henning Skjønsberg, Haseem Ashraf and Bernt B. Aarli and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Kristian Tonby

27 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristian Tonby Norway	15	424	255	210	123	116	30	711
Phil‐Robin Tepasse Germany	12	419 1.0×	236 0.9×	85 0.4×	87 0.7×	77 0.7×	41	683
Yimei Yin China	7	231 0.5×	158 0.6×	89 0.4×	103 0.8×	48 0.4×	8	563
Almina Jukic Austria	6	141 0.3×	145 0.6×	100 0.5×	211 1.7×	83 0.7×	11	558
Inés López-Alonso Spain	16	222 0.5×	89 0.3×	126 0.6×	145 1.2×	158 1.4×	29	721
Qianchuan Huang China	6	635 1.5×	346 1.4×	88 0.4×	120 1.0×	61 0.5×	14	818
Yingjie Qi China	7	688 1.6×	376 1.5×	95 0.5×	156 1.3×	129 1.1×	28	955
Andrew I. Bayliffe United Kingdom	10	370 0.9×	122 0.5×	71 0.3×	169 1.4×	146 1.3×	16	814
Inge Grondman Netherlands	10	213 0.5×	108 0.4×	140 0.7×	109 0.9×	146 1.3×	16	486
Işık Atagündüz Türkiye	6	464 1.1×	240 0.9×	47 0.2×	154 1.3×	124 1.1×	23	753
Stephany Beyerstedt Brazil	4	332 0.8×	162 0.6×	47 0.2×	107 0.9×	44 0.4×	11	593

Countries citing papers authored by Kristian Tonby

Since Specialization

Citations

This map shows the geographic impact of Kristian Tonby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristian Tonby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristian Tonby more than expected).

Fields of papers citing papers by Kristian Tonby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristian Tonby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristian Tonby. The network helps show where Kristian Tonby may publish in the future.

Co-authorship network of co-authors of Kristian Tonby

This figure shows the co-authorship network connecting the top 25 collaborators of Kristian Tonby. A scholar is included among the top collaborators of Kristian Tonby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristian Tonby. Kristian Tonby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindemann, Paul Christoffer, Aasmund Fostervold, Per Kristian Knudsen, et al.. (2024). Gentamicin should remain part of the empirical sepsis regimen for adults. Tidsskrift for Den norske legeforening. 144(3).

Barratt‐Due, Andreas, Jan Cato Holter, Anne Ma Dyrhol‐Riise, et al.. (2024). Escalated complement activation during hospitalization is associated with higher risk of 60‐day mortality in SARS‐CoV‐2‐infected patients. Journal of Internal Medicine. 296(1). 80–92. 4 indexed citations

Alonso‐Rodríguez, Noelia, Suzanne van Veen, Synne Jenum, et al.. (2024). Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy. Frontiers in Immunology. 15. 1350593–1350593. 1 indexed citations

Skeie, Linda Gail, Ingrid M. Egner, Adity Chopra, et al.. (2024). Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections. npj Vaccines. 9(1). 185–185. 2 indexed citations

Sagen, Ellen Lund, Annika E. Michelsen, Trine Kåsine, et al.. (2024). High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID‐19 patients: Results from the NOR‐Solidarity trial. Journal of Internal Medicine. 296(3). 249–259.

Trøseid, Marius, Jan Cato Holter, Kristian Holm, et al.. (2023). Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19. Critical Care. 27(1). 69–69. 24 indexed citations

Scriba, Thomas J., Martin Kidd, Simon C. Mendelsohn, et al.. (2022). Utility of a three-gene transcriptomic signature in the diagnosis of tuberculosis in a low-endemic hospital setting. Infectious Diseases. 55(1). 44–54. 2 indexed citations

Jenum, Synne, Kristian Tonby, Corina S. Rueegg, et al.. (2021). A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. Nature Communications. 12(1). 6774–6774. 50 indexed citations

Dahl, Tuva B., Kuan Yang, Trine Ranheim, et al.. (2021). Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns. Journal of Internal Medicine. 290(3). 677–692. 17 indexed citations

10.

Vitelli, Valeria, Ewan Carr, Aleksander Rygh Holten, et al.. (2021). Regional performance variation in external validation of four prediction models for severity of COVID-19 at hospital admission: An observational multi-centre cohort study. PLoS ONE. 16(8). e0255748–e0255748. 2 indexed citations

11.

Aass, Hans Christian D., Emilie Layre, Jérôme Nigou, et al.. (2021). Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients. Frontiers in Cellular and Infection Microbiology. 11. 669623–669623. 5 indexed citations

12.

Tonby, Kristian, Synne Jenum, Martin Kidd, et al.. (2021). A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries. Frontiers in Immunology. 12. 608846–608846. 18 indexed citations

13.

Tonby, Kristian, Synne Jenum, Susanne Dam Nielsen, et al.. (2021). CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries. Journal of Infection. 83(4). 433–443. 5 indexed citations

14.

Lerum, Tøri Vigeland, Trond Mogens Aaløkken, Eivind Brønstad, et al.. (2020). Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. European Respiratory Journal. 57(4). 2003448–2003448. 220 indexed citations

15.

Dyrhol‐Riise, Anne Ma, et al.. (2020). Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease. Frontiers in Immunology. 11. 579849–579849. 25 indexed citations

16.

Holten, Aleksander Rygh, et al.. (2020). Predicting severe COVID-19 in the Emergency Department. Resuscitation Plus. 4. 100042–100042. 23 indexed citations

17.

Mortensen, Rasmus, Joshua S. Woodworth, Tehmina Mustafa, et al.. (2019). Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice. Communications Biology. 2(1). 288–288. 31 indexed citations

18.

Tonby, Kristian, et al.. (2015). Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors. PLoS ONE. 10(11). e0141903–e0141903. 19 indexed citations

19.

Tonby, Kristian, Morten Rühwald, Dag Kvale, & Anne Ma Dyrhol‐Riise. (2015). IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection. Scientific Reports. 5(1). 42 indexed citations

20.

Feruglio, Siri Laura, Kristian Tonby, Dag Kvale, & Anne Ma Dyrhol‐Riise. (2014). Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of activeMycobacterium tuberculosisinfection. Clinical & Experimental Immunology. 179(3). 454–465. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact